Cargando…
MAP1B rescues LRRK2 mutant-mediated cytotoxicity
Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common cause of dominant and sporadic Parkinson’s disease (PD), a common neurodegenerative disorder. Yeast-two-hybrid screening using human LRRK2 kinase domain as bait identified microtubule associated protein 1B (MAP1B) as a LRRK2 interact...
Autores principales: | Chan, Sharon L, Chua, Ling-Ling, Angeles, Dario C, Tan, Eng-King |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022373/ https://www.ncbi.nlm.nih.gov/pubmed/24754922 http://dx.doi.org/10.1186/1756-6606-7-29 |
Ejemplares similares
-
Chetomin rescues pathogenic phenotype of LRRK2 mutation in drosophila
por: Chua, Ling Ling, et al.
Publicado: (2020) -
Identification of Targets from LRRK2 Rescue Phenotypes
por: Toh, Joanne, et al.
Publicado: (2021) -
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype
por: Rassu, Mauro, et al.
Publicado: (2019) -
Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2
por: Angeles, Dario C., et al.
Publicado: (2016) -
Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)